09 feb 2021
COVID-19 related dermatosis in November 2019
Milan, the largest city in northern Italy, was one of the first European metropolitan areas to be affected by the COVID-19 pandemic.
09 feb 2021
Real-life experience with oral oxybutynin long-term continuous therapy
Hyperhidrosis is a disorder of excessive sweating severely impacting on patient's quality of life (Qol).
09 feb 2021
The dermoscopic inverse approach significantly
A recently introduced dermoscopic method for the diagnosis of early lentigo maligna
09 feb 2021
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Psoriasis is a chronic inflammatory disease characterised by sharply demarcated erythematous and scaly skin lesions accompanied by systemic manifestations.
04 feb 2021
A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences
A multicenter study of nevus-associated melanoma
04 feb 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study
The clinical spectrum of COVID-19-associated cutaneous manifestations
04 feb 2021
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides
Italian expert-based recommendations on the use of photo(chemo)therapy
27 gen 2021
Studio italiano manifestazioni cutanee del Sars-CoV-2
La rassegna stampa del comunicato lanciato stamattina sullo studio italiano manifestazioni cutanee del Sars-CoV-2.
26 gen 2021
Diagnosis of toenail onychomycosis by an immunochromatographic dermatophytes test strip
Diagnosis of toenail onychomycosis is based in current practice on direct microscopic examination (DME) and fungal cultures of nail samples.
26 gen 2021
Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides
Mycosis fungoides (MF) comprises 54% of cutaneous T cell lymphomas. Although the etiology is unknown, prior studies have shown that MF is more common in males than females, with greater incidence in African Americans (AAs).
26 gen 2021
Epithelioid Kaposi Sarcoma
Cutaneous Kaposi sarcoma (KS) covers a broad spectrum both clinically and pathologically. Some histological patterns of KS may be difficult to recognize and must be differentiated from other vascular neoplasms.
25 gen 2021
Manuale RAO (Raggruppamenti di Attesa Omogenei)
Newsletter di AGENAS relativa ai Servizi Sanitari Regionali
13 gen 2021
Celastrol: un approccio dermocosmetico alla psoriasi da scoprire
Il Celastrol, ed il ruolo dell’emolliente nella psoriasi
13 gen 2021
Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association
The co-existence of hidradenitis suppurativa (HS) and atopic dermatitis (AD) had been reported but was not investigated in controlled studies.
13 gen 2021
Pruritus Intensity Scales across Europe: A Prospective Validation Study
Chronic pruritus (CP) is a subjective symptom and it is necessary to assess its intensity with validated patient-reported outcome tools in order to allow determination of the treatment course
13 gen 2021
Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
Checkpoint inhibitor (CPI) therapy has vastly improved long-term outcomes in metastatic malignant melanoma (MMM)
12 gen 2021
L’infermiere specialista in dermatologia
L'infermiere specialista in dermatologia ha esperienza e competenze per mettere in atto il Processo di Nursing
06 gen 2021
Vaccino anti covid e patologie dermatologiche
Pazienti affetti da patologie infiammatorie croniche (psoriasi, dermatite atopica, idrosadenite suppurativa etc.) e da patologie tumorali
05 gen 2021
Copertura assicurativa AON In convenzione SIDeMaST
SIDeMaST ha realizzato, in collaborazione con il broker Aon, una nuova copertura a tutela del patrimonio del professionista in caso di infortunio.
04 gen 2021
Convenzioni Assicurative Polizza Infortuni
Convenzioni Assicurative Polizza Infortuni